Literature DB >> 18638593

Association of coronary atherosclerosis detected by multislice computed tomography and traditional risk-factor assessment.

Deepu Nair1, Thomas P Carrigan, Ronan J Curtin, Zoran B Popovic, Stacie Kuzmiak, Paul Schoenhagen, Scott D Flamm, Milind Y Desai.   

Abstract

Framingham risk score is an office-based tool used for long-term coronary heart disease risk stratification. Most acute coronary events occur in association with proximal nonobstructive atherosclerotic plaque. Multislice computed tomography detects both obstructive coronary artery disease (CAD) and proximal atherosclerotic plaque with high accuracy. The association of Framingham risk score with obstructive CAD and proximal atherosclerotic plaque was tested. Coronary multislice computed tomography was performed in 295 patients (61% men, mean age 54 +/- 13 years) without documented CAD referred for evaluation of cardiac symptoms. Framingham risk score was computed and patients were stratified according to 10-year risk (n = 213 [72%] low, n = 74 [25%] intermediate, and n = 8 [3%] high). Obstructive CAD was defined as > or =50% stenosis in > or =1 epicardial coronary artery. Proximal atherosclerotic plaque was defined as calcified or noncalcified plaque in the left main or proximal left anterior descending artery. In the low- and intermediate-Framingham risk score groups, there was a high frequency of proximal atherosclerotic plaque (44% and 75%) and obstructive CAD (16% and 34%), although both findings were more prevalent in the high-Framingham risk score group (63% for atherosclerotic plaque, 88% for obstructive CAD), respectively. Proximal atherosclerotic plaque was noncalcified in approximately 13 of patients. In women (n = 114) and younger (<55 years) patients (n = 148), most (93% and 91%, respectively) had a low Framingham risk score. There were 48 women and 51 younger patients with proximal atherosclerotic plaque, of whom only 40% (in each group) were on statin therapy. In conclusion, of patients with a low and intermediate Framingham risk score, a significant proportion had proximal atherosclerotic plaque or obstructive CAD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18638593     DOI: 10.1016/j.amjcard.2008.03.058

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Evaluation of the appropriateness criteria for coronary computed tomography angiography in an academic medical center in a developing country: comparison of the 2006 and 2010 criteria.

Authors:  Katia El Sibai; Salam Itani; Ali Rabah; Mukbil Hourani; Habib A Dakik
Journal:  J Nucl Cardiol       Date:  2011-08-11       Impact factor: 5.952

2.  Prevalence of coronary artery disease across the Framingham risk categories: coronary artery calcium scoring and MSCT coronary angiography.

Authors:  Gaetano Nucifora; Joanne D Schuijf; Jacob M van Werkhoven; J Wouter Jukema; Roxana Djaberi; Arthur J H A Scholte; Albert de Roos; Martin J Schalij; Ernst E van der Wall; Jeroen J Bax
Journal:  J Nucl Cardiol       Date:  2009-02-14       Impact factor: 5.952

3.  Evaluation of differences in carotid intima-media thickness in patients affected by systemic rheumatic diseases.

Authors:  Marco Matteo Ciccone; Pietro Scicchitano; Annapaola Zito; Francesca Cortese; Cinzia Rotondo; Laura Coladonato; Michele Gesualdo; Antonella Notarnicola; Florenzo Iannone
Journal:  Intern Emerg Med       Date:  2015-06-03       Impact factor: 3.397

4.  Clinical effectiveness of coronary computed tomographic angiography in the triage of patients to cardiac catheterization and revascularization after inconclusive stress testing: results of a 2-year prospective trial.

Authors:  Aiden Abidov; Michael J Gallagher; Kavitha M Chinnaiyan; Laxmi S Mehta; James H Wegner; Gilbert L Raff
Journal:  J Nucl Cardiol       Date:  2009-07-22       Impact factor: 5.952

5.  Comparison of Framingham, PROCAM, SCORE, and Diamond Forrester to predict coronary atherosclerosis and cardiovascular events.

Authors:  Mathijs O Versteylen; Ivo A Joosen; Leslee J Shaw; Jagat Narula; Leonard Hofstra
Journal:  J Nucl Cardiol       Date:  2011-07-19       Impact factor: 5.952

Review 6.  Innovative Approaches to Assess Intermediate Cardiovascular Risk Subjects: A Review From Clinical to Metabolomics Strategies.

Authors:  Aline M A Martins; Mariana U B Paiva; Diego V N Paiva; Raphaela M de Oliveira; Henrique L Machado; Leonardo J S R Alves; Carolina R C Picossi; Andréa T Faccio; Marina F M Tavares; Coral Barbas; Viviane Z R Giraldez; Raul D Santos; Guilherme U Monte; Fernando A Atik
Journal:  Front Cardiovasc Med       Date:  2021-12-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.